ACTIVE

Relst Pharma

Export PDF
Financial year 2025 · closed on 31/12/2025
Net result
104,9 k €
-37.3% YoY
Gross margin
168,7 k €
-13.1% YoY
Equity
473,3 k €
+28.5% YoY
Workforce
0,3 ETP

What does Relst Pharma do?

Relst Pharma is a Private limited company incorporated in 1990. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Kampenhout. It employs on average 0,3 ETP workers (FTE).

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0441.339.112
Incorporation
09/07/1990
Legal form
Private limited company
Registered office
Haachtsesteenweg 512
1910 Kampenhout · FlandreSee on map
Contributed capital
6 200,00 €
Latest accounts
31/12/2025
Average workforce
0,3 ETP
Activities (NACE)
47730Dispensing chemist in specialised stores· main47730Dispensing chemist in specialised stores52310Warehousing and support activities for transportation
Joint committees (2)
  • 313
  • 3130
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 15 financial years

202520242023202220212020201920182012201120102009200820072006
Income statement
Gross margin168,7 k €194,2 k €136,1 k €147,9 k €156 k €127,6 k €86,4 k €66,9 k €154,6 k €140,2 k €127 k €139,7 k €129,9 k €138,8 k €129 k €
EBITDA149 k €189,3 k €130,7 k €144,3 k €154,1 k €124,7 k €78,6 k €14,8 k €78 k €64,1 k €53,8 k €64,6 k €44,2 k €60 k €53,5 k €
Operating result139,7 k €181,7 k €123 k €136,9 k €149,2 k €118,4 k €73,5 k €7,7 k €23,2 k €10,6 k €5,6 k €17,8 k €2 k €36 k €31,6 k €
Net result104,9 k €167,5 k €116,1 k €132,1 k €133,7 k €107,2 k €44,7 k €2,3 k €-12,5 k €76,9 k €-10,5 k €5,8 k €-7,9 k €21,9 k €20,4 k €
Balance sheet
Equity473,3 k €368,4 k €323,9 k €307,8 k €300,7 k €267 k €248,3 k €203,6 k €73,3 k €85,8 k €123,9 k €134,4 k €128,5 k €136,5 k €125,5 k €
Total assets714,5 k €668,9 k €686,8 k €547,6 k €637,4 k €539,8 k €477,9 k €451,4 k €375,8 k €402,9 k €441,4 k €489,3 k €502,6 k €371 k €333,2 k €
Cash104,3 k €66,3 k €102,9 k €49,7 k €145,2 k €76 k €45,8 k €37,5 k €56,7 k €8,5 k €51,7 k €62,4 k €43 k €110,4 k €95,1 k €
Debts241,2 k €300,5 k €362,9 k €239,8 k €336,8 k €271,7 k €228,5 k €247,8 k €302,5 k €317,1 k €315,9 k €355 k €374,1 k €234,5 k €207,7 k €
Other
Workforce0,3 ETP0,0 ETP0,0 ETP0,0 ETP–––1,3 ETP1,1 ETP1,0 ETP1,1 ETP1,1 ETP1,6 ETP1,6 ETP1,7 ETP
Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 6 ended

Active mandates

Giura Pharma

Director · since 01 mai 2018 · 0692.655.422

Represented by Caroline Caenepeel

Active
Pharma Deprée

Director · since 01 mai 2018 · 0692.655.719

Represented by Inne Deprée

Active

Ended mandates

Giura Pharma

Manager · since 01 mai 2018 · 0692.655.422

Represented by Caroline Caenepeel

Ended
Pharma Deprée

Manager · since 01 mai 2018 · 0692.655.719

Represented by Inne Deprée

Ended
Reinhilde Berden

Manager · since 09 juillet 1990

Ended
Giura Pharma

Director · 0692.655.422

Represented by Caroline Caenepeel

Ended
Annual accounts

Full financial information

202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date09/06/202623/07/202501/07/202409/11/202308/08/202229/09/2021
General meeting02/06/202630/06/202503/06/202406/11/202307/06/202207/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

20 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202502/06/202609/06/2026DutchPDF
Abridged model31/12/202430/06/202523/07/2025DutchPDF
Abridged model31/12/202303/06/202401/07/2024DutchPDF
Abridged model31/12/202206/11/202309/11/2023DutchPDF
Abridged model31/12/202107/06/202208/08/2022DutchPDF
Abridged model31/12/202007/06/202129/09/2021DutchPDF
Abridged model31/12/201902/06/202031/10/2020DutchPDF
Abridged model31/12/201803/06/201913/08/2019DutchPDF
Abridged model31/12/201704/06/201825/07/2018DutchPDF
Abridged model31/12/201605/06/201730/08/2017DutchPDF
Abridged model31/12/201506/06/201623/08/2016DutchPDF
Abridged model31/12/201401/06/201524/08/2015DutchPDF
Abridged model31/12/201302/06/201426/08/2014DutchPDF
Abridged model31/12/201203/06/201330/08/2013DutchPDF
Abridged model31/12/201104/06/201228/06/2012DutchPDF
Abridged model31/12/201020/03/201130/03/2011DutchPDF
Abridged model31/12/200907/06/201030/06/2010DutchPDF
Abridged model31/12/200801/06/200910/07/2009DutchPDF
Abridged model31/12/200702/06/200809/06/2008DutchPDF
Abridged model31/12/200604/06/200714/06/2007DutchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 6 ended

Active mandates

Giura Pharma

Director · since 01 mai 2018 · 0692.655.422

Represented by Caroline Caenepeel

Active
Pharma Deprée

Director · since 01 mai 2018 · 0692.655.719

Represented by Inne Deprée

Active

Ended mandates

Giura Pharma

Manager · since 01 mai 2018 · 0692.655.422

Represented by Caroline Caenepeel

Ended
Pharma Deprée

Manager · since 01 mai 2018 · 0692.655.719

Represented by Inne Deprée

Ended
Reinhilde Berden

Manager · since 09 juillet 1990

Ended
Giura Pharma

Director · 0692.655.422

Represented by Caroline Caenepeel

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates03/04/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - DOEL - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates10/07/2018
    BENAMING - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING
    PDF
  • Capital / shares05/02/2004
    ALGEMENE VERGADERING - KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025104,9 k €↓
  2. 2024
    Annual accounts 2024167,5 k €↑
  3. 2023
    Annual accounts 2023116,1 k €↓
  4. 2022
    Annual accounts 2022132,1 k €↓
  5. 2021
    Annual accounts 2021133,7 k €↑
  6. 2020
    Annual accounts 2020107,2 k €↑
  7. 2019
    Annual accounts 201944,7 k €↑
  8. 2018
    Annual accounts 20182,3 k €↑
  9. 2012
    Annual accounts 2012-12,5 k €↓
  10. 2011
    Annual accounts 201176,9 k €↑
  11. 2010
    Annual accounts 2010-10,5 k €↓
  12. 2009
    Annual accounts 20095,8 k €↑
  13. 2008
    Annual accounts 2008-7,9 k €↓
  14. 2007
    Annual accounts 200721,9 k €↑
  15. 2006
    Annual accounts 200620,4 k €
  16. 09/07/1990
    IncorporationPrivate limited company